These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 1786517)

  • 41. Alpha 2-adrenergic agonist and alpha 1-adrenergic antagonist activity of ergotamine and dihydroergotamine in rats.
    Roquebert J; Grenié B
    Arch Int Pharmacodyn Ther; 1986 Nov; 284(1):30-7. PubMed ID: 2881518
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Affinities of fluoxetine, its enantiomers, and other inhibitors of serotonin uptake for subtypes of serotonin receptors.
    Wong DT; Threlkeld PG; Robertson DW
    Neuropsychopharmacology; 1991 Aug; 5(1):43-7. PubMed ID: 1930610
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Agonist-induced phosphoinositide hydrolysis in choroid plexus.
    Conn PJ; Sanders-Bush E
    J Neurochem; 1986 Dec; 47(6):1754-60. PubMed ID: 3021903
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Lack of effect of the antimigraine drugs, sumatriptan, ergotamine and dihydroergotamine on arteriovenous anastomotic shunting in the dura mater of the pig.
    den Boer MO; Somers JA; Saxena PR
    Br J Pharmacol; 1992 Oct; 107(2):577-83. PubMed ID: 1330188
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A single point mutation (Phe340-->Leu340) of a conserved phenylalanine abolishes 4-[125I]iodo-(2,5-dimethoxy)phenylisopropylamine and [3H]mesulergine but not [3H]ketanserin binding to 5-hydroxytryptamine2 receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1993 May; 43(5):755-61. PubMed ID: 8388989
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Chronic clozapine treatment decreases 5-hydroxytryptamine1C receptor density in the rat choroid plexus: comparison with haloperidol.
    Kuoppamäki M; Seppälä T; Syvälahti E; Hietala J
    J Pharmacol Exp Ther; 1993 Mar; 264(3):1262-7. PubMed ID: 8383744
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Identification of receptor domains that modify ligand binding to 5-hydroxytryptamine2 and 5-hydroxytryptamine1c serotonin receptors.
    Choudhary MS; Craigo S; Roth BL
    Mol Pharmacol; 1992 Oct; 42(4):627-33. PubMed ID: 1435740
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Exploratory hypoactivity induced by m-trifluoromethylphenylpiperazine (TFMPP) and m-chlorophenylpiperazine (m-CPP).
    Kłodzińska A; Jaros T; Chojnacka-Wójcik E; Maj J
    J Neural Transm Park Dis Dement Sect; 1989; 1(3):207-18. PubMed ID: 2775468
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Differential inactivation and G protein reconstitution of subtypes of [3H]5-hydroxytryptamine binding sites in brain.
    Stratford CA; Tan GL; Hamblin MW; Ciaranello RD
    Mol Pharmacol; 1988 Oct; 34(4):527-36. PubMed ID: 3139989
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Studies on 5-hydroxytryptamine receptors on isolated human femoral veins and arteries and the influence of dihydroergotamine.
    Glusa E; Markwardt F
    Pharmacology; 1984; 29(6):336-42. PubMed ID: 6505006
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Relative efficacies of piperazines at the phosphoinositide hydrolysis-linked serotonergic (5-HT-2 and 5-HT-1c) receptors.
    Conn PJ; Sanders-Bush E
    J Pharmacol Exp Ther; 1987 Aug; 242(2):552-7. PubMed ID: 3039120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evidence for 5-HT1B/1D receptors mediating the antimigraine effect of sumatriptan and dihydroergotamine.
    Buzzi MG; Moskowitz MA
    Cephalalgia; 1991 Sep; 11(4):165-8. PubMed ID: 1660351
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Characterization of the contractile serotonergic receptor in guinea pig trachea with agonists and antagonists.
    Watts SW; Cohen ML
    J Pharmacol Exp Ther; 1992 Mar; 260(3):1101-6. PubMed ID: 1312158
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Dual effect of dihydroergotamine at vascular 5-hydroxytryptamine receptors in pithed rats.
    Müller H; Glusa E; Markwardt F
    Pharmacology; 1988; 37(4):248-53. PubMed ID: 2904153
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clozapine and N-desmethylclozapine are potent 5-HT1C receptor antagonists.
    Kuoppamäki M; Syvälahti E; Hietala J
    Eur J Pharmacol; 1993 Apr; 245(2):179-82. PubMed ID: 8387927
    [TBL] [Abstract][Full Text] [Related]  

  • 56. High and low affinity 5-HT2 and 5-HT1C binding sites: responses to neonatal 5,7-DHT lesions in rat brain.
    Pranzatelli MR; Gregory CM
    Cytobios; 1993; 75(302-303):197-209. PubMed ID: 8243108
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Molecular pharmacological differences in the interaction of serotonin with 5-hydroxytryptamine1C and 5-hydroxytryptamine2 receptors.
    Leonhardt S; Gorospe E; Hoffman BJ; Teitler M
    Mol Pharmacol; 1992 Aug; 42(2):328-35. PubMed ID: 1355262
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A short history of the 5-HT
    Palacios JM; Pazos A; Hoyer D
    Psychopharmacology (Berl); 2017 May; 234(9-10):1395-1418. PubMed ID: 28265714
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endothelial relaxing 5-hydroxytryptamine receptors in the rat jugular vein: similarity with the 5-hydroxytryptamine1C receptor.
    Bodelsson M; Törnebrandt K; Arneklo-Nobin B
    J Pharmacol Exp Ther; 1993 Feb; 264(2):709-16. PubMed ID: 8437119
    [TBL] [Abstract][Full Text] [Related]  

  • 60. On the pharmacology of venous smooth muscle from dog and man.
    Müller-Schweinitzer E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1979; 106(5-6):690-704. PubMed ID: 94863
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.